Aflibercept for age-related macular degeneration: 4-year outcomes of a ‘treat-and-extend’ regimen with exit-strategy

AIM: To report long-term outcomes on best-corrected visual acuity (BCVA) and treatment intervals with a treat-and-extend (T&E) regimen in patients with neovascular age-related macular degeneration (nAMD). METHODS: This observational study included treatment-naïve patients with nAMD, treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaggi, Damian, Nagamany, Thanoosha, Ebneter, Andreas, Munk, Marion, Wolf, Sebastian, Zinkernagel, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788035/
https://www.ncbi.nlm.nih.gov/pubmed/33127830
http://dx.doi.org/10.1136/bjophthalmol-2020-316514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788035/
https://www.ncbi.nlm.nih.gov/pubmed/33127830
http://dx.doi.org/10.1136/bjophthalmol-2020-316514

Ejemplares similares